| | | | | | | | | | |
|
Dockets Management
|
| Dockets Entered On
July 13, 2006
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1998D-0315
|
| Instructions for Submitting Electronic Lot Release Protocols
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
|
| 2004P-0339
|
| Refuse to file an ANDA for the combination drug amlodipine besylate-benazepril hydrochloride (amlodipine-benazepril)
|
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
|
|
| 2005N-0437
|
| Medical Gas Containers and Closures; Current Good Manufacturing
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| 2006D-0226
|
| Prescription Drug Marketing Act Pedigree Requirements under 21 CFR Part 203; Effective Date and Compliance Policy GuideProgram, Draft Guidance; Availability
|
|
|
| 2006N-0181
|
| Product Stability Data: Notice of Pilot Project
|
|
|
| 2006P-0151
|
| Stay the current approvable letter with conditions of any and all Premarket Applications for silicone gel-filled breast implants
|
|
|
| 2006P-0177
|
| ANDA Suitability for Methotrexate
|
|
|
| 1998D-0315
|
| Instructions for Submitting Electronic Lot Release Protocols
|
|
|
| GDL 2
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
| NAD 2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2003D-0478
|
| Guidance on Marketed Unapproved Drugs Compliance Policy Guide
|
|
|
| EC 27
|
| Ms. Jennifer MacSwain
|
| Vol #:
|
| 5
|
|
|
| 2004P-0339
|
| Refuse to file an ANDA for the combination drug amlodipine besylate-benazepril hydrochloride (amlodipine-benazepril)
|
|
|
| PAV 1
|
| FDA/CDER to Fommer Lawrence & Haug LLP
|
| Vol #:
|
| 1
|
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
|
|
| MO 14
|
| FDA/CDDDRH/OGC
|
| Vol #:
|
| 6
|
|
|
| 2005N-0437
|
| Medical Gas Containers and Closures; Current Good Manufacturing
|
|
|
| C 37
|
| Cryogenic Vessel Alternatives
|
| Vol #:
|
| 3
|
|
|
| C 38
|
| Tech Air of Connecticut, Inc.
|
| Vol #:
|
| 3
|
|
|
| C 39
|
| Corp Brother, Inc.
|
| Vol #:
|
| 3
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| C 15491
|
| S. Carden
|
| Vol #:
|
| 172
|
|
|
| C 15492
|
| J. Baran
|
| Vol #:
|
| 172
|
|
|
| C 15493
|
| G. Weitzel
|
| Vol #:
|
| 172
|
|
|
| C 15494
|
| J. Montgomery
|
| Vol #:
|
| 172
|
|
|
| C 15495
|
| D. Hudrich
|
| Vol #:
|
| 172
|
|
|
| C 15496
|
| J. Sargent
|
| Vol #:
|
| 172
|
|
|
| C 15497
|
| J. Malkin
|
| Vol #:
|
| 172
|
|
|
| C 15498
|
| M. Caldwell
|
| Vol #:
|
| 172
|
|